IPM Biopharm is Biotechnology in China that focus on cell therapies business. Founded in 2015. They cover business area such as developer, precision medical technology, cell therapy, human life, prolong life expectancy, research, field, stem cell-base drug, immune cell therapeutic technology, genetically modify cell line, biological reagent, cell detection, cell storage, patient.
2015
( 9 years old in 2024 )
Cell Therapies
-
5th Floor, Block D, Building 2, Shulan Hospital
No.848 Dongxin Road, Xiacheng District
Hangzhou, Zhejiang
China
Private
developerprecision medical technologycell therapyhuman lifeprolong life expectancyresearchfieldstem cell-base drugimmune cell therapeutic technologygenetically modify cell linebiological reagentcell detectioncell storagepatient
* We use standard office opening hours in near IPM Biopharm's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
IPM Biopharm is Biotechnology business from China that founded in 2015 (9 years old in 2024), IPM Biopharm business is focusing on Cell Therapies.
IPM Biopharm headquarter office and corporate office address is located in 5th Floor, Block D, Building 2, Shulan Hospital No.848 Dongxin Road, Xiacheng District Hangzhou, Zhejiang China.
IPM Biopharm was founded in China.
In 2024, IPM Biopharm is currently focus on cell therapies sector.
Above is snippet of Google Trends for "cell therapies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with IPM Biopharm, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
